FDA — authorised 27 September 1967
- Status: approved
FDA authorised Triptil on 27 September 1967
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 27 September 1967.
Marketing authorisation holder not available in our data.